0	5	Block	Block	NNP
6	8	of	of	IN
9	21	granulocytic	granulocytic	JJ
22	37	differentiation	differentiation	NN
38	40	of	of	IN
41	47	32Dcl3	32dcl3	NN
48	53	cells	cell	NNS
54	56	by	by	IN
57	71	AML1/ETO(MTG8)	AML1/ETO(MTG8)	NNP
72	75	but	but	CC
76	79	not	not	RB
80	82	by	by	IN
83	89	highly	highly	RB
90	99	expressed	express	VBN
100	105	Bcl-2	bcl-2	NN
105	106	.	.	.

108	111	The	the	DT
112	120	chimeric	chimeric	JJ
121	125	gene	gene	NN
125	126	,	,	,
127	135	AML1/ETO	AML1/ETO	NNP
136	137	(	(	(
137	141	MTG8	MTG8	NNP
141	142	)	)	)
142	143	,	,	,
144	153	generated	generate	VBN
154	156	in	in	IN
157	164	t(8;21)	t(8;21)	NN
165	170	acute	acute	JJ
171	178	myeloid	myeloid	JJ
179	187	leukemia	leukemia	NN
188	196	enhances	enhance	VBZ
197	200	the	the	DT
201	211	expression	expression	NN
212	214	of	of	IN
215	220	Bcl-2	bcl-2	NN
220	221	.	.	.

222	224	To	to	TO
225	233	evaluate	evaluate	VB
234	241	whether	whether	IN
242	246	this	this	DT
247	258	enhancement	enhancement	NN
259	261	is	be	VBZ
262	265	the	the	DT
266	273	primary	primary	JJ
274	278	role	role	NN
279	281	of	of	IN
282	290	AML1/ETO	AML1/ETO	NNP
291	293	in	in	IN
294	308	leukemogenesis	leukemogenesis	NN
308	309	,	,	,
310	317	effects	effect	NNS
318	320	of	of	IN
321	336	over-expression	over-expression	NN
337	339	of	of	IN
340	345	Bcl-2	bcl-2	NN
346	348	in	in	IN
349	352	the	the	DT
353	359	murine	murine	JJ
360	367	myeloid	myeloid	JJ
368	377	precursor	precursor	NN
378	382	cell	cell	NN
383	387	line	line	NN
387	388	,	,	,
389	395	32Dcl3	32Dcl3	NNP
395	396	,	,	,
397	401	were	be	VBD
402	410	examined	examine	VBN
410	411	.	.	.

412	416	When	when	WRB
417	423	32Dcl3	32dcl3	NN
424	429	cells	cell	NNS
430	440	expressing	express	VBG
441	450	exogenous	exogenous	JJ
451	456	Bcl-2	bcl-2	NN
457	461	were	be	VBD
462	469	induced	induce	VBN
470	472	to	to	TO
473	486	differentiate	differentiate	VB
486	487	,	,	,
488	491	the	the	DT
492	497	onset	onset	NN
498	500	of	of	IN
501	514	morphological	morphological	JJ
515	530	differentiation	differentiation	NN
531	534	was	be	VBD
535	542	delayed	delay	VBN
542	543	.	.	.

544	551	However	however	RB
551	552	,	,	,
553	557	even	even	RB
558	561	the	the	DT
562	567	cells	cell	NNS
568	578	expressing	express	VBG
579	583	very	very	RB
584	588	high	high	JJ
589	595	levels	level	NNS
596	598	of	of	IN
599	608	exogenous	exogenous	JJ
609	614	Bcl-2	bcl-2	NN
615	625	eventually	eventually	RB
626	635	underwent	undergo	VBD
636	651	differentiation	differentiation	NN
652	659	without	without	IN
660	661	a	a	DT
662	673	significant	significant	JJ
674	682	decrease	decrease	NN
683	685	in	in	IN
686	689	the	the	DT
690	699	synthesis	synthesis	NN
700	702	of	of	IN
703	708	Bcl-2	bcl-2	NN
708	709	.	.	.

710	712	On	on	IN
713	716	the	the	DT
717	725	contrary	contrary	NN
725	726	,	,	,
727	733	32Dcl3	32dcl3	NN
734	739	cells	cell	NNS
740	746	stably	stably	RB
747	757	expressing	express	VBG
758	766	AML1/ETO	aml1/eto	NN
767	771	were	be	VBD
772	782	completely	completely	RB
783	792	resistant	resistant	JJ
793	795	to	to	TO
796	811	differentiation	differentiation	NN
812	815	and	and	CC
816	825	continued	continue	VBD
826	828	to	to	TO
829	833	grow	grow	VB
834	836	in	in	IN
837	840	the	the	DT
841	849	presence	presence	NN
850	852	of	of	IN
853	858	G-CSF	G-CSF	NNP
858	859	.	.	.

860	865	These	these	DT
866	873	results	result	NNS
874	877	are	be	VBP
878	888	consistent	consistent	JJ
889	893	with	with	IN
894	897	the	the	DT
898	912	interpretation	interpretation	NN
913	917	that	that	IN
918	929	stimulation	stimulation	NN
930	932	of	of	IN
933	938	Bcl-2	bcl-2	NN
939	949	expression	expression	NN
950	952	is	be	VBZ
953	956	not	not	RB
957	960	the	the	DT
961	968	primary	primary	JJ
969	975	target	target	NN
976	978	of	of	IN
979	987	AML1/ETO	AML1/ETO	NNP
987	988	.	.	.